Healthy Patients

Antimicrobial resistance (AMR)
AMR develops when bacteria, fungi or viruses are exposed to antibiotics, antifungals or antivirals. As a result, the antimicrobials become ineffective and infections may persist. In addition, medical interventions including surgery, chemotherapy and stem cell therapy may become impossible.
AMR is considered the biggest global threat of Health and Food Safety.
AMR Insights
For Healthcare professionals who wish to prevent Antimicrobial resistance, AMR Insights offers selected, global information and data, specific education and extensive networking and partnering opportunities.
AMR Insights is for:
- Medical Microbiologists, Infectiologists and other specialists
- General Practitioners, Pharmacists
- Infection Prevention Experts and nurses
- Medical Docters and Caretakers in nursing homes
- Managers and Labtechnicians of Microbiological Laboratories.
Latest Topics
-
10 August 2025
Quadripartite launches the Working Group on Youth Engagement for Antimicrobial Resistance
The Quadripartite, including the Food and Agriculture Organization of the United Nations, United Nations Environment Programme, World Health Organization, and World Organization for Animal Health, has established a Working Group on Youth Engagement for Antimicrobial Resistance (AMR). The group will guide efforts to raise awareness and involve young people in global AMR action. AMR occurs […]
Read more... -
10 August 2025
Global variation in Antibiotic Prescribing Guidelines and the implications for decreasing AMR in the future
This study evaluates antibiotic prescribing guidelines, particularly among low- and middle-income countries (LMICs), to improve antibiotic use quality and reduce antimicrobial resistance (AMR). 181 guidelines were included, with the majority originating from high-income countries. The GRADE methodology was used in only 20.4% of the guidelines. Patient education was often underemphasized, particularly in LMICs. The findings […]
Read more... -
10 August 2025
Challenges of assessing the cost effectiveness of AMR campaigns: Considerations for policy makers
This study examines the cost-effectiveness of antimicrobial resistance (AMR) campaigns and highlights challenges in existing methodologies. It identifies challenges in measuring clinical outcomes, including broader societal impacts, capturing relevant outcomes over longer timescales, and accounting for AMR costs. The findings suggest that little methodological progress has been made in this area over the past 20 […]
Read more...
More news related to Healthy patients